HRTX

Healthcare

Heron Therapeutics, Inc.

$0.90-0.03 (-3.27%)

Prev Close

$0.93

Open

$0.96

High

$0.96

Low

$0.89

Volume

1.67M

Market Cap

$154.8M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Heron Therapeutics, Inc. (HRTX) has been exclusively buying, with 1 insider purchase totaling $2.65M and 0 insider sales totaling $0.00. The most recent insider transaction was by Morgan Adam (Director), who purchased $2.65M worth of shares on Aug 8, 2025. Heron Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $154.8M.

Buys (12M)

$2.65M

Sells (12M)

$0.00

Net Activity

Net Buyer

$2.65M

Active Insiders

last 12 mo

HRTX Price Chart

HRTX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 8, 2025↗	Morgan Adam	Director	Buy	1,766,546	$1.50	$2.65M	0
Nov 21, 2023↗	Forbes William P	EVP, Chief Development Officer	Buy	25,000	$1.09	$27.3K	79,000
Nov 20, 2023↗	Forbes William P	EVP, Chief Development Officer	Buy	50,000	$0.94	$47.0K	54,000
Nov 17, 2023↗	Collard Craig A	Chief Executive Officer	Buy	150,000	$0.92	$138.0K	186,496
Nov 17, 2023↗	Duarte Ira	EVP, Chief Financial Officer	Buy	85,000	$0.89	$75.6K	85,000
Jul 25, 2023↗	Morgan Adam	Director	Buy	3,649,635	$1.37	$5.00M	6,986,740
May 4, 2022↗	MANHARD KIMBERLY	EVP, Drug Development	Sell	1,504	$4.76	$7.2K	10,872
Dec 23, 2021↗	Christian Waage	Director	Sell	300	$9.73	$2.9K	3,200
Dec 23, 2021↗	Johnson Craig A	Director	Sell	250	$9.73	$2.4K	2,840
Sep 23, 2021↗	Christian Waage	Director	Sell	300	$12.31	$3.7K	3,500
Sep 23, 2021↗	Johnson Craig A	Director	Sell	250	$12.30	$3.1K	3,090
Jun 22, 2021↗	Christian Waage	Director	Sell	300	$15.20	$4.6K	3,800
Jun 22, 2021↗	Johnson Craig A	Director	Sell	250	$15.20	$3.8K	3,340
May 4, 2021↗	MANHARD KIMBERLY	EVP, Drug Development	Sell	1,529	$17.66	$27.0K	1,634
Apr 16, 2021↗	Christian Waage	Director	Sell	300	$17.51	$5.3K	4,100
Apr 7, 2021↗	Johnson Craig A	Director	Sell	250	$17.22	$4.3K	3,590

HRTX Insider Buying Activity

The following table shows recent insider purchases of Heron Therapeutics, Inc. (HRTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 8, 2025↗	Morgan Adam	Director	Buy	1,766,546	$1.50	$2.65M	0
Nov 21, 2023↗	Forbes William P	EVP, Chief Development Officer	Buy	25,000	$1.09	$27.3K	79,000
Nov 20, 2023↗	Forbes William P	EVP, Chief Development Officer	Buy	50,000	$0.94	$47.0K	54,000
Nov 17, 2023↗	Collard Craig A	Chief Executive Officer	Buy	150,000	$0.92	$138.0K	186,496
Nov 17, 2023↗	Duarte Ira	EVP, Chief Financial Officer	Buy	85,000	$0.89	$75.6K	85,000
Jul 25, 2023↗	Morgan Adam	Director	Buy	3,649,635	$1.37	$5.00M	6,986,740

HRTX Insider Selling Activity

The following table shows recent insider sales of Heron Therapeutics, Inc. (HRTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 4, 2022↗	MANHARD KIMBERLY	EVP, Drug Development	Sell	1,504	$4.76	$7.2K	10,872
Dec 23, 2021↗	Christian Waage	Director	Sell	300	$9.73	$2.9K	3,200
Dec 23, 2021↗	Johnson Craig A	Director	Sell	250	$9.73	$2.4K	2,840
Sep 23, 2021↗	Christian Waage	Director	Sell	300	$12.31	$3.7K	3,500
Sep 23, 2021↗	Johnson Craig A	Director	Sell	250	$12.30	$3.1K	3,090
Jun 22, 2021↗	Christian Waage	Director	Sell	300	$15.20	$4.6K	3,800
Jun 22, 2021↗	Johnson Craig A	Director	Sell	250	$15.20	$3.8K	3,340
May 4, 2021↗	MANHARD KIMBERLY	EVP, Drug Development	Sell	1,529	$17.66	$27.0K	1,634
Apr 16, 2021↗	Christian Waage	Director	Sell	300	$17.51	$5.3K	4,100
Apr 7, 2021↗	Johnson Craig A	Director	Sell	250	$17.22	$4.3K	3,590